Guinea-Bissau vs United Kingdom of Great Britain and Northern Ireland: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Guinea-Bissau
90.0%
in 2025
United Kingdom of Great Britain and Northern Ireland
89.0%
in 2025
Guinea-Bissau rank
70th
United Kingdom of Great Britain and Northern Ireland rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Guinea-Bissau
- United Kingdom of Great Britain and Northern Ireland
How they compare
Guinea-Bissau currently reports 90.0% against 89.0% in United Kingdom of Great Britain and Northern Ireland, a difference of 1.0%.
The two have swapped places 1 time across 18 shared years of data; in 2008 it was United Kingdom of Great Britain and Northern Ireland ahead.
Guinea-Bissau ranks 70th and United Kingdom of Great Britain and Northern Ireland ranks 72nd of 194 countries.
United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Guinea-Bissau | United Kingdom of Great Britain and Northern Ireland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 34.1% | 91.7% | 57.6% | United Kingdom of Great Britain and Northern Ireland |
| 2020s | 85.5% | 89.8% | 4.3% | United Kingdom of Great Britain and Northern Ireland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Guinea-Bissau or United Kingdom of Great Britain and Northern Ireland?
- Guinea-Bissau, at 90.0% against 89.0% in United Kingdom of Great Britain and Northern Ireland as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Guinea-Bissau and United Kingdom of Great Britain and Northern Ireland?
- 1.0%, with Guinea-Bissau ahead.
- How many years of comparable data are there for Guinea-Bissau and United Kingdom of Great Britain and Northern Ireland?
- 18 years are reported by both, from 2008 to 2025.
- How do Guinea-Bissau and United Kingdom of Great Britain and Northern Ireland rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Guinea-Bissau ranks 70th and United Kingdom of Great Britain and Northern Ireland ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.